Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy

[1]  M. Menon,et al.  Aberrant modulation of brain activation by emotional valence during self-referential processing among patients with delusions of reference. , 2017, Journal of behavior therapy and experimental psychiatry.

[2]  Valentin Riedl,et al.  Changes in extra-striatal functional connectivity in patients with schizophrenia in a psychotic episode , 2017, British Journal of Psychiatry.

[3]  J. Downar,et al.  Cortico-Striatal-Thalamic Loop Circuits of the Salience Network: A Central Pathway in Psychiatric Disease and Treatment , 2016, Front. Syst. Neurosci..

[4]  J. Mann,et al.  Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study , 2016, Scientific Reports.

[5]  J. Mann,et al.  Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study , 2016, Psychological Medicine.

[6]  Andrew Zalesky,et al.  Delayed Development of Brain Connectivity in Adolescents With Schizophrenia and Their Unaffected Siblings. , 2015, JAMA psychiatry.

[7]  A. Malhotra,et al.  Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. , 2015, The American journal of psychiatry.

[8]  L. Uddin.  Salience processing and insular cortical function and dysfunction , 2014, Nature Reviews Neuroscience.

[9]  Jimmy Lee,et al.  Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis. , 2014, Schizophrenia bulletin.

[10]  Michael W. Cole,et al.  Altered global brain signal in schizophrenia , 2014, Proceedings of the National Academy of Sciences.

[11]  Peter B. Jones,et al.  Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. , 2013, JAMA psychiatry.

[12]  Melissa J. Green,et al.  Task-related fronto-striatal functional connectivity during working memory performance in schizophrenia , 2013, Schizophrenia Research.

[13]  Dimitris Mavridis,et al.  Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis , 2013, The Lancet.

[14]  W. Honer,et al.  Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients , 2013, Schizophrenia Research.

[15]  Marc Joliot,et al.  Links among resting-state default-mode network, salience network, and symptomatology in schizophrenia , 2013, Schizophrenia Research.

[16]  S. Kapur,et al.  Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients , 2012, Biological Psychiatry.

[17]  P. Szeszko,et al.  Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. , 2012, Schizophrenia bulletin.

[18]  O. Grimm,et al.  Reduced striatal activation during reward anticipation due to appetite-provoking cues in chronic schizophrenia: A fMRI study , 2012, Schizophrenia Research.

[19]  T. Eichele,et al.  Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia , 2012, Schizophrenia bulletin.

[20]  H. Critchley,et al.  An Interoceptive Predictive Coding Model of Conscious Presence , 2011, Front. Psychology.

[21]  E. Bullmore,et al.  Disrupted Axonal Fiber Connectivity in Schizophrenia , 2011, Biological Psychiatry.

[22]  V. Menon,et al.  Saliency, switching, attention and control: a network model of insula function , 2010, Brain Structure and Function.

[23]  A. Heinz,et al.  Dopaminergic dysfunction in schizophrenia: salience attribution revisited. , 2010, Schizophrenia bulletin.

[24]  H. Critchley,et al.  A common role of insula in feelings, empathy and uncertainty , 2009, Trends in Cognitive Sciences.

[25]  S. Kapur,et al.  The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.

[26]  Kevin Murphy,et al.  The impact of global signal regression on resting state correlations: Are anti-correlated networks introduced? , 2009, NeuroImage.

[27]  B. Biswal,et al.  Functional connectivity of human striatum: a resting state FMRI study. , 2008, Cerebral cortex.

[28]  V. Menon,et al.  A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks , 2008, Proceedings of the National Academy of Sciences.

[29]  Peter Williamson,et al.  Are anticorrelated networks in the brain relevant to schizophrenia? , 2007, Schizophrenia bulletin.

[30]  P. Fletcher,et al.  From prediction error to psychosis: ketamine as a pharmacological model of delusions , 2007, Journal of psychopharmacology.

[31]  Brian Knutson,et al.  Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics , 2006, Psychopharmacology.

[32]  S. Kapur,et al.  From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis , 2005, Schizophrenia Research.

[33]  S. Kapur,et al.  Half a century of antipsychotics and still a central role for dopamine D2 receptors , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  R. Conley,et al.  Management of treatment resistance in schizophrenia , 2001, Biological Psychiatry.

[35]  J. Pekar,et al.  A method for making group inferences from functional MRI data using independent component analysis , 2001, Human brain mapping.

[36]  E. Bullmore,et al.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Robbins,et al.  Frontal-striatal cognitive deficits in patients with chronic schizophrenia. , 1997, Brain : a journal of neurology.

[38]  P. Seeman,et al.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.

[39]  A. Malhotra,et al.  Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. , 2015, JAMA psychiatry.

[40]  P. Liddle,et al.  Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. , 2012, Journal of psychiatry & neuroscience : JPN.

[41]  R. Buckner,et al.  The organization of the human striatum estimated by intrinsic functional connectivity. , 2012, Journal of neurophysiology.

[42]  P. McGuire,et al.  Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis , 2011, Molecular Psychiatry.

[43]  Marisa O. Hollinshead,et al.  The organization of the human cerebral cortex estimated by intrinsic functional connectivity , 2011 .

[44]  H. Holcomb,et al.  Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex , 2004, Neuropsychopharmacology.

[45]  S. Kapur.  Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.

[46]  S. Tanada,et al.  Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. , 2002, Archives of general psychiatry.

[47]  Karl J. Friston,et al.  Schizophrenia: a disconnection syndrome? , 1995, Clinical neuroscience.